
|Articles|October 15, 2003
Spreading agent approval sought for hyaluronidase
Irvine, CA-ISTA Pharmaceuticals is seeking FDA approval to use hyaluronidase (Vitrase) as a spreading agent to facilitate the dispersion and absorption of other drugs.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain
2
Q&A: What’s in the glaucoma treatment pipeline?
3
Low-dose pilocarpine shrinks pupil without altering accommodation in presbyopia
4
2026 from an OD's perspective: What is on the horizon
5



























